Session

Mechanisms in lower GI disease I (Posters)

EPITHELIAL CGAS/STING GUIDES DNA DAMAGE-DRIVEN STEM CELL FUNCTION AND PROTECTS FROM INTESTINAL CARCINOGENESIS
EPITHELIAL CGAS/STING GUIDES DNA DAMAGE-DRIVEN STEM CELL FUNCTION AND PROTECTS FROM INTESTINAL CARCINOGENESIS

HIGH INTESTINAL SECRETORY LEUKOCYTE PROTEASE INHIBITOR EXPRESSION CORRELATES WITH ABUNDANT NEUTROPHILIC INFLAMMATION AND IDENTIFIES INFLAMMATORY BOWEL DISEASE PATIENTS WITH A STRONG IL-17 RESPONSE
HIGH INTESTINAL SECRETORY LEUKOCYTE PROTEASE INHIBITOR EXPRESSION CORRELATES WITH ABUNDANT NEUTROPHILIC INFLAMMATION AND IDENTIFIES INFLAMMATORY BOWEL DISEASE PATIENTS WITH A STRONG IL-17 RESPONSE

SEROLOGICAL BIOMARKERS OF TYPE I, III, AND IV COLLAGEN TURNOVER ARE ASSOCIATED WITH THE PRESENCE AND FUTURE PROGRESSION OF STRICTURING AND PENETRATING CROHN'S DISEASE
SEROLOGICAL BIOMARKERS OF TYPE I, III, AND IV COLLAGEN TURNOVER ARE ASSOCIATED WITH THE PRESENCE AND FUTURE PROGRESSION OF STRICTURING AND PENETRATING CROHN'S DISEASE

UNDERSTANDING THE IMPACT OF PREVIOUS TNF-ALPHA INHIBITORS ON VEDOLIZUMAB RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE USING SYSTEMATIC REVIEW AND GENE EXPRESSION DATA
UNDERSTANDING THE IMPACT OF PREVIOUS TNF-ALPHA INHIBITORS ON VEDOLIZUMAB RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE USING SYSTEMATIC REVIEW AND GENE EXPRESSION DATA

EFFECT OF OLD AGE ON THE SUBPOPULATIONS OF ENTERIC GLIAL CELLS IN HUMAN DESCENDING COLON
EFFECT OF OLD AGE ON THE SUBPOPULATIONS OF ENTERIC GLIAL CELLS IN HUMAN DESCENDING COLON

TRANSFORMING GROWTH FACTOR BETA SIGNALING IN CANCER-ASSOCIATED FIBROBLASTS DRIVES A HEPATIC, GP130 DEPENDENT PRO-METASTATIC INFLAMMATORY PROGRAM IN CMS4 TYPE COLORECTAL CANCER
TRANSFORMING GROWTH FACTOR BETA SIGNALING IN CANCER-ASSOCIATED FIBROBLASTS DRIVES A HEPATIC, GP130 DEPENDENT PRO-METASTATIC INFLAMMATORY PROGRAM IN CMS4 TYPE COLORECTAL CANCER

EFFECTS OF SACCHAROMYCES BOULARDII CNCM I-745 ON GUT DYSBIOSIS AND ALTERED EPITHELIAL BARRIER INTEGRITY IN A MURINE MODEL OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED ENTEROPATHY
EFFECTS OF SACCHAROMYCES BOULARDII CNCM I-745 ON GUT DYSBIOSIS AND ALTERED EPITHELIAL BARRIER INTEGRITY IN A MURINE MODEL OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED ENTEROPATHY

PROTECTIVE EFFECTS OF SACCHAROMYCES BOULARDII CNCM I-745 IN AN EXPERIMENTAL MODEL OF NSAID-INDUCED ENTEROPATHY
PROTECTIVE EFFECTS OF SACCHAROMYCES BOULARDII CNCM I-745 IN AN EXPERIMENTAL MODEL OF NSAID-INDUCED ENTEROPATHY

EOSINOPHILS IN COLONIC DIVERTICULAR DISEASE
EOSINOPHILS IN COLONIC DIVERTICULAR DISEASE

EOSINOPHILS IN COLONIC DIVERTICULAR DISEASE
EOSINOPHILS IN COLONIC DIVERTICULAR DISEASE

Mechanisms in lower GI disease I (Posters)  et al.

PROTECTIVE EFFECTS OF SACCHAROMYCES BOULARDII CNCM I-745 IN AN EXPERIMENTAL MODEL OF NSAID-INDUCED ENTEROPATHY
PROTECTIVE EFFECTS OF SACCHAROMYCES BOULARDII CNCM I-745 IN AN EXPERIMENTAL MODEL OF NSAID-INDUCED ENTEROPATHY

Mechanisms in lower GI disease I (Posters)  et al.

EFFECTS OF SACCHAROMYCES BOULARDII CNCM I-745 ON GUT DYSBIOSIS AND ALTERED EPITHELIAL BARRIER INTEGRITY IN A MURINE MODEL OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED ENTEROPATHY
EFFECTS OF SACCHAROMYCES BOULARDII CNCM I-745 ON GUT DYSBIOSIS AND ALTERED EPITHELIAL BARRIER INTEGRITY IN A MURINE MODEL OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG-INDUCED ENTEROPATHY

Mechanisms in lower GI disease I (Posters)  et al.

TRANSFORMING GROWTH FACTOR BETA SIGNALING IN CANCER-ASSOCIATED FIBROBLASTS DRIVES A HEPATIC, GP130 DEPENDENT PRO-METASTATIC INFLAMMATORY PROGRAM IN CMS4 TYPE COLORECTAL CANCER
TRANSFORMING GROWTH FACTOR BETA SIGNALING IN CANCER-ASSOCIATED FIBROBLASTS DRIVES A HEPATIC, GP130 DEPENDENT PRO-METASTATIC INFLAMMATORY PROGRAM IN CMS4 TYPE COLORECTAL CANCER

Mechanisms in lower GI disease I (Posters)  et al.

EFFECT OF OLD AGE ON THE SUBPOPULATIONS OF ENTERIC GLIAL CELLS IN HUMAN DESCENDING COLON
EFFECT OF OLD AGE ON THE SUBPOPULATIONS OF ENTERIC GLIAL CELLS IN HUMAN DESCENDING COLON

Mechanisms in lower GI disease I (Posters)  et al.

UNDERSTANDING THE IMPACT OF PREVIOUS TNF-ALPHA INHIBITORS ON VEDOLIZUMAB RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE USING SYSTEMATIC REVIEW AND GENE EXPRESSION DATA
UNDERSTANDING THE IMPACT OF PREVIOUS TNF-ALPHA INHIBITORS ON VEDOLIZUMAB RESPONSE IN PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE USING SYSTEMATIC REVIEW AND GENE EXPRESSION DATA

Mechanisms in lower GI disease I (Posters)  et al.

SEROLOGICAL BIOMARKERS OF TYPE I, III, AND IV COLLAGEN TURNOVER ARE ASSOCIATED WITH THE PRESENCE AND FUTURE PROGRESSION OF STRICTURING AND PENETRATING CROHN'S DISEASE
SEROLOGICAL BIOMARKERS OF TYPE I, III, AND IV COLLAGEN TURNOVER ARE ASSOCIATED WITH THE PRESENCE AND FUTURE PROGRESSION OF STRICTURING AND PENETRATING CROHN'S DISEASE

Mechanisms in lower GI disease I (Posters)  et al.

HIGH INTESTINAL SECRETORY LEUKOCYTE PROTEASE INHIBITOR EXPRESSION CORRELATES WITH ABUNDANT NEUTROPHILIC INFLAMMATION AND IDENTIFIES INFLAMMATORY BOWEL DISEASE PATIENTS WITH A STRONG IL-17 RESPONSE
HIGH INTESTINAL SECRETORY LEUKOCYTE PROTEASE INHIBITOR EXPRESSION CORRELATES WITH ABUNDANT NEUTROPHILIC INFLAMMATION AND IDENTIFIES INFLAMMATORY BOWEL DISEASE PATIENTS WITH A STRONG IL-17 RESPONSE

Mechanisms in lower GI disease I (Posters)  et al.

EPITHELIAL CGAS/STING GUIDES DNA DAMAGE-DRIVEN STEM CELL FUNCTION AND PROTECTS FROM INTESTINAL CARCINOGENESIS
EPITHELIAL CGAS/STING GUIDES DNA DAMAGE-DRIVEN STEM CELL FUNCTION AND PROTECTS FROM INTESTINAL CARCINOGENESIS

Mechanisms in lower GI disease I (Posters)  et al.

Item 1 - 18 / 18
1